# TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia

> **NCT04033627** · NA · UNKNOWN · sponsor: **Shanghai Children's Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Relapsed Pediatric ALL
- Acute Graft-Versus-Host Disease (Gvhd) Grade IV (Diagnosis)
- Relapsed Pediatric AML

## Interventions

- **PROCEDURE:** In Vitro T cells depletion using CliniMCAS system

## Key facts

- **NCT ID:** NCT04033627
- **Lead sponsor:** Shanghai Children's Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-10
- **Primary completion:** 2022-07-18
- **Final completion:** 2024-05-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-09-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04033627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04033627, "TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04033627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*